Abstract
Purpose : We determined whether genetic variability in the gene encoding for tumor necrosis factor-α (TNF-α) contributes to individual differences in susceptibility to the development of preeclampsia.
Methods : The study involved 133 preeclamptic and 115 healthy control pregnant women who were genotyped for C-850T polymorphism in the TNF-α gene promoter. Chi-square analysis was used to assess genotype and allele frequency differences between preeclamptic women and controls.
Results : A significantly different genotype distribution of C-850T polymorphism was observed between the two groups, with the frequency of the variant T allele being significantly reduced in the preeclamptic group (4.5%) when compared with the control group (9.6%) (P = 0.03; OR = 0.45, 95% CI = 0.22–0.92). Accordingly, the odds ratio for preeclampsia associated with the pooled TT and CT genotypes was 0.367 (P = 0.02; 95% CI = 0.159–0.847).
Conclusions : The T allele of the TNF-α gene may modify individual preeclampsia risk, being protective against the development of the complication.
Similar content being viewed by others
REFERENCES
Arngrimsson R, Bjö rnsson H, Geirsson R: Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertens Pregn 1995;14:27–38
Cincotta RB, Brennecke SP: Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998;60:23–27
Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, Catalano PM: The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998;179:1032–1037
Jonsdottir L, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N: Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995;74: 772–776
Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P: Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DR beta. Lancet 1990;336:653–657
Humphrey KE, Harrison GA, Cooper DW, Wilton AN, Brennecke SP, Trudinger BJ: HLA-G deletion polymorphism and pre-eclampsia/eclampsia. Br J Obstet Gynaecol 1995;102:707–710
Chen G, Wilson R, Boyd P, Mckillop JH, Leitch C, Walker JJ, Burdon RH: Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: Is the decreased SOD activity a secondary phenomenon? Free Radic Res 1994;21:59–66
Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59–61
Dizon-Townson DS, Nelson LM, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902–905
Zusterzeel PL, Peters WH, Visser W, Hermsen KJ, Roelofs HM, Steegers EA: A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet 2001;38:234–237
Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T: Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997;34:525–526
Arngrimsson R, Sigurardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, Baldursdottir A, Einarsdottir AS, Palsson B, Snorradottir S, Lachmeijer AM, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefansson K: A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999;8:1799–1805
Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP: A genome scan in families fromAustralia andNewZealand confirms the presence of a maternal susceptibility locus for preeclampsia, on chromosome 2. Am J Hum Genet 2000;67:1581– 1585
Harrison GA, Humphrey KE, Jones N, Badenhop R, Guo G, Elakis G, Kaye JA, Turner RJ, Grehan M, Wilton AN, Brennecke SP, Cooper DW: A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997;60:1158–1167
Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, Bjarnadottir RI, Brock DJ, Geirsson RT, Connor JM, Soubrier F: Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997;61:354–362
Lewis I, Lachmeijer G, Downing S, Dekker G, Glazebrook C, Clayton D, Morris NH, O'Shaughnessy KM: Failure to detect linkage of preeclampsia to the region of the NOS3 locus on chromosome 7q. Am J Hum Genet 1999;64:310–313
Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr, nnett WA: Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1 beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999;181:915–920
Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, Quasney M, Sibai BM: Lack of association of severe preeclampsia with maternal and fetal mutantalleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasmatumor necrosis factor alpha levels. Am J Obstet Gynecol 2001;184:1273–1277
Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP: Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505– 2512
Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression inpre-eclampsia. Clin Exp Immunol 1996;104:154–159
Lachmeijer AM, Crusius JB, Pals G, Dekker GA, Arngrimsson R, ten Kate LP: Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia. Obstet Gynecol 2001;98:612–619
Kilpatrick DC: HLA-dependent TNF secretory response may provide an immunogenetic link between pre-eclampsia and type 1 diabetes mellitus. Dis Markers 1996;13:43–47
Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B: Macrophage-induced apoptosis limits endovascular trophoblast invasion in theuterine wall of preeclamptic women. Lab Invest 2001;81:1143–1152
Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999;8:1913– 1923
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22
Kato T, Honda M, Kuwata S, Juji T, Kunugi H, Nanko S, Fukuda M, Honda Y: Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy. Am J Med Genet 1999;88:301–304
Chesley L, Annitto L, Cosgrave R: The familial factor in toxemia of pregnancy. Obstet Gynecol 1968;32:303–311
Meydani SN, Dinarello CA: Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65–72
Williams MA, Zingheim RW, King IB, Zebelman AM: Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995;6:232–237
Ruuls SR, Sedgwick JD: Unlinking tumor necrosis factor biology from the major histocompatibility complex: Lessons from human genetics and animal models. Am J Hum Genet 1999;65:294–301
Dizon-Townson DS, Major H, Ward K: A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia. J Reprod Immunol 1998;38:55–61
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heiskanen, J., Romppanen, EL., Hiltunen, M. et al. Polymorphism in the Tumor Necrosis Factor-α Gene in Women with Preeclampsia. J Assist Reprod Genet 19, 220–223 (2002). https://doi.org/10.1023/A:1015306818507
Issue Date:
DOI: https://doi.org/10.1023/A:1015306818507